午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Stat1 (phospho Tyr701)兔多抗,Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody
  • Stat1 (phospho Tyr701)兔多抗,Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody
  • Stat1 (phospho Tyr701)兔多抗,Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody

Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩璣生命

價(jià)格 詢價(jià)
包裝 1支
最小起訂量 1支
發(fā)貨地 湖北
更新日期 2025-08-13
微信洽談

產(chǎn)品詳情

中文名稱:Stat1 (phospho Tyr701)兔多抗英文名稱:Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody
品牌: EnkiLife產(chǎn)地: 中國(guó)
產(chǎn)品類別: 抗體
是否進(jìn)口: 用途: 科研
2025-08-13 Stat1 (phospho Tyr701)兔多抗 Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody 1支/RMB EnkiLife 中國(guó) 抗體

產(chǎn)品概述

產(chǎn)品名稱(Product Name)

Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody

描述(Description)

Rabbit Polyclonal Antibody

宿主(Host)

Rabbit

應(yīng)用(Application)

IF-P,IF-F,ICC/IF,WB,IHC-P,IP,ELISA

種屬反應(yīng)性(Reactivity)

Human,Mouse,Rat,Monkey

 

產(chǎn)品性能

偶聯(lián)物(Conjugation)

Unconjugated

修飾(Modification)

Phospho Antibody

同種型(Isotype)

IgG

克隆(Clonality)

Polyclonal

形式(Form)

Liquid

存放說(shuō)明(Storage)

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

儲(chǔ)存溶液(Buffer)

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

純化方式(Purification)

Affinity purification

 

免疫原

基因名(Gene Name)

STAT1

別名(Alternative Names)

STAT1; Signal transducer and activator of transcription 1-alpha/beta; Transcription factor ISGF-3 components p91/p84

基因ID(Gene ID)

6772

蛋白ID(SwissProt ID)

P42224

 

產(chǎn)品應(yīng)用

稀釋比(Dilution Ratio)

IF-P/IF-F/ICC/IF 1:50-200, WB 1:500-1:2000, IHC-P 1:100-1:300, Immunoprecipitation 2-5 ug/mg lysate, ELISA 1:10000.Not yet tested in other applications.

蛋白分子量(Molecular Weight)

87kDa

 

研究背景

The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. Two alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008],disease:Defects in STAT1 are a cause of mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950]; also known as familial disseminated atypical mycobacterial infection. This rare condition confers predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine and environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. The pathogenic mechanism underlying MSMD is the impairment of interferon-gamma mediated immunity whose severity determines the clinical outcome. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. MSMD is a genetically heterogeneous disease with autosomal recessive, autosomal dominant or X-linked inheritance.,disease:Defects in STAT1 are the cause of STAT1 deficiency [MIM:600555]. Patients generally suffer from mycobacterial or viral diseases. In the case of complete deficiency, patients can die of viral disease.,function:Signal transducer and activator of transcription that mediates signaling by interferons (IFNs). Following type I IFN (IFN-alpha and IFN-beta) binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with ISGF3G/IRF-9 to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state. In response to type II IFN (IFN-gamma), STAT1 is tyrosine- and serine-phosphorylated. It then forms a homodimer termed IFN-gamma-activated factor (GAF), migrates into the nucleus and binds to the IFN gamma activated sequence (GAS) to drive the expression of the target genes, inducing a cellular antiviral state.,online information:STAT1 entry,online information:STAT1 mutation db,PTM:Phosphorylated on tyrosine and serine residues in response to IFN-alpha, IFN-gamma, PDGF and EGF. Phosphorylation on Tyr-701 (lacking in beta form) by JAK promotes dimerization and subsequent translocation to the nucleus. Phosphorylation on Ser-727 by several kinases including MAPK14, ERK1/2 and CAMKII on IFN-gamma stimulation, regulates STAT1 transcriptional activity. Phosphorylation on Ser-727 promotes sumoylation though increasing interaction with PIAS. Phosphorylation on Ser-727 by PKCdelta induces apoptosis in response to DNA-damaging agents.,PTM:Sumoylated by SUMO1, SUMO2 and SUMO3. Sumoylation is enhanced by IFN-gamma-induced phosphorylation on Ser-727, and by interaction with PIAS proteins. Enhances the transactivation activity.,similarity:Belongs to the transcription factor STAT family.,similarity:Contains 1 SH2 domain.,subcellular location:Translocated into the nucleus in response to IFN-gamma-induced tyrosine phosphorylation and dimerization.,subunit:Isoform alpha homodimerizes upon IFN-gamma induced phosphorylation. Heterodimer with STAT2 upon IFN-alpha/beta induced phosphorylation. Interacts with NMI. Interacts with Sendai virus C', C, Y1 and Y2 proteins, Nipah virus P, V and W proteins, and rabies virus phosphoprotein preventing activation of ISRE and GAS promoter (By similarity). Interacts with HCV core protein; the interaction results in STAT1 degradation. Interacts with PIAS1; the interaction requires phosphorylation on Ser-727 and inhibits STAT1 activation.,

 

研究領(lǐng)域

Chemokine;Toll_Like;Jak_STAT;Pathways in cancer;Pancreatic cancer;

關(guān)鍵字: STAT1;Stat1;(phospho;Tyr701);Rabbit;Polyclonal;Antibody;一抗

公司簡(jiǎn)介

武漢恩璣生命科技有限公司(EnkiLife)是一家深耕生命科學(xué),專注細(xì)胞生物學(xué)和免疫學(xué)科研試劑的研發(fā)、生產(chǎn)與銷售的生物技術(shù)企業(yè),在全球100多個(gè)國(guó)家和地區(qū)開展業(yè)務(wù),致力于為科研工作者提供高質(zhì)量的產(chǎn)品和卓越的客戶服務(wù),推動(dòng)生命科學(xué)的發(fā)展。 EnkiLife的產(chǎn)品線涵蓋細(xì)胞系、原代細(xì)胞、細(xì)胞培養(yǎng)基、血清、細(xì)胞檢測(cè)試劑盒、重組靶點(diǎn)蛋白、細(xì)胞因子、重組抗體、ELISA試劑盒、生化試劑盒等,并提供技術(shù)服務(wù)與定制開發(fā),覆蓋了生命科學(xué)研究的各大關(guān)鍵領(lǐng)域,包括細(xì)胞生物學(xué)、癌癥、免疫學(xué)、神經(jīng)科學(xué)、心血管疾病、干細(xì)胞、表觀遺傳學(xué)、內(nèi)分泌、蛋白質(zhì)組學(xué)、代謝組學(xué)等,全方位滿足您的實(shí)驗(yàn)需求,讓您享受科研的樂(lè)趣! 公司現(xiàn)已建立四大技術(shù)平臺(tái): EnCyto?細(xì)胞培養(yǎng)及檢測(cè)平臺(tái):擁有細(xì)胞系庫(kù)(500+)、原代細(xì)胞庫(kù)(500+)、基礎(chǔ)培養(yǎng)基和完全培養(yǎng)基(1200+) EnkiPro?重組蛋白平臺(tái):現(xiàn)貨產(chǎn)品2000+,可提供定制化表達(dá)服務(wù) EnAb?重組抗體平臺(tái):重組兔單抗(3000+),可提供定制化和標(biāo)記服務(wù) EnKits?試劑盒開發(fā)平臺(tái):可提供優(yōu)質(zhì)的ELISA試劑盒、配套試劑、抗體對(duì)、生化試劑盒等相關(guān)產(chǎn)品 EnkiLife在生產(chǎn)管理方面引入ISO9001質(zhì)量管理體系和信息化、自動(dòng)化的管理工具,擁有高效穩(wěn)定的交付能力,與全球知名品牌建立了緊密的合作。 EnkiLife始終堅(jiān)持以技術(shù)創(chuàng)新為驅(qū)動(dòng),以匠心鑄就品質(zhì),以品質(zhì)服務(wù)客戶。 我們期待與更多的全球科研工作者和企業(yè)攜手合作,共同推動(dòng)生命科學(xué)領(lǐng)域的進(jìn)步與發(fā)展。
成立日期 2024-08-02 (2年) 注冊(cè)資本 271萬(wàn)人民幣
員工人數(shù) 10-50人 年?duì)I業(yè)額 ¥ 100萬(wàn)-300萬(wàn)
主營(yíng)行業(yè) 生化試劑,抗體,細(xì)胞培養(yǎng),癌癥研究,細(xì)胞生物學(xué) 經(jīng)營(yíng)模式 工廠,試劑,定制,服務(wù)
  • 武漢恩璣生命科技有限公司
VIP 1年
  • 公司成立:2年
  • 注冊(cè)資本:271萬(wàn)人民幣
  • 企業(yè)類型:有限責(zé)任公司(自然人投資或控股)
  • 主營(yíng)產(chǎn)品:細(xì)胞系;原代細(xì)胞;培養(yǎng)基;血清;細(xì)胞熒光染料;重組蛋白;抗體;標(biāo)記試劑盒;WB試劑盒;IHC試劑盒;ELISA試劑盒;生化試劑盒
  • 公司地址:東湖新技術(shù)開發(fā)區(qū)高新大道666號(hào)C6棟
詢盤

Stat1 (phospho Tyr701) Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩璣生命相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
VIP1年
上海切爾齊生物科技有限公司
2025-06-03
¥2310
武漢艾美捷科技有限公司
2025-08-02
詢價(jià)
碧云天生物技術(shù)有限公司
2025-08-02
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的
主頁(yè) | 企業(yè)會(huì)員服務(wù) | 廣告業(yè)務(wù) | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學(xué)品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 |投訴中心
Copyright ? 2008 ChemicalBook 京ICP備07040585號(hào)  京公海網(wǎng)安備110108000080號(hào)  All rights reserved.